Myomo
80 hedge funds and large institutions have $8.65M invested in Myomo in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 11 closing their positions.
45% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 11
5% more funds holding
Funds holding: 76 → 80 (+4)
9% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 23
3.69% less ownership
Funds ownership: 36.92% → 33.23% (-3.7%)
33% less capital invested
Capital invested by funds: $12.9M → $8.65M (-$4.26M)
Top Buyers
| 1 |
LPL Financial
San Diego,
California
|
+$106K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$99.8K |
| 3 |
Renaissance Technologies
New York
|
+$19.3K |
| 4 |
IMC Chicago
Chicago,
Illinois
|
+$18.3K |
| 5 |
IC
IEQ Capital
Foster City,
California
|
+$17.5K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$279K |
| 2 |
Goldman Sachs
New York
|
-$271K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$203K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$161K |
| 5 |
CC
Centiva Capital
New York
|
-$131K |
MYO Hedge Fund Activity: Q1 2026 in Review
80 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Myomo (MYO) for Q1 2026, worth a combined $8.65M — down 33% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new MYO positions and 11 closed out — a net gain of 5 holders — while 21 added to existing stakes and 23 trimmed.
The largest buyer was LPL Financial, adding an estimated $106K. The largest seller was Morgan Stanley, cutting an estimated $279K.
- 80 institutional investors held Myomo (MYO) as of Q1 2026, up from 76 in Q4 2025.
- Funds reported $8.65M of Myomo stock for Q1 2026, down 33% quarter-over-quarter.
- 16 funds opened new Myomo positions in Q1 2026 and 11 closed out, a net change of +5 holders.
- The largest Myomo buyer in Q1 2026 was LPL Financial, an estimated $106K added.
- The largest Myomo seller in Q1 2026 was Morgan Stanley, an estimated $279K sold.
Based on aggregated 13F filings for Q1 2026.